Kartogenin enhances the therapeutic effect of bone marrow mesenchymal stem cells derived exosomes in cartilage repair
Abstract
The effectiveness of mesenchymal stem cells (MSC) in the treatment of cartilage diseases has been demonstrated to be attributed to the paracrine mechanisms, especially the mediation of exosomes. But the exosomes derived from unsynchronized MSCs may be nonhomogeneous and the therapeutic effect varies between samples. Aim: To produce homogeneous and more effective exosomes for the regeneration of cartilage. Materials & methods: In this study we produced specific exosomes from bone marrow MSCs (BMSC) through kartogenin (KGN) preconditioning and investigated their performance in either in vitro or in vivo experiments. Results & conclusion: The exosomes derived from KGN-preconditioned BMSCs (KGN-BMSC-Exos) performed more effectively than the exosomes derived from BMSCs (BMSC-Exos). KGN preconditioning endowed BMSC-Exos with stronger chondral matrix formation and less degradation.
Papers of special note have been highlighted as: • of interest
References
- 1. Updated projected prevalence of self-reported doctor-diagnosed arthritis and arthritis-attributable activity limitation among US adults, 2015–2040. Arthritis Rheumatol. 68(7), 1582–1587 (2016).
- 2. . Chemistry. Repair or replacement – a joint perspective. Science 323(5910), 47–48 (2009).
- 3. Treatment of knee osteoarthritis with allogeneic bone marrow mesenchymal stem cells. Transplantation 99(8), 1681–1690 (2015).
- 4. . The life and fate of mesenchymal stem cells. Front. Immunol. 5(5), 148 (2014).
- 5. Paracrine mechanisms of mesenchymal stem cell-based therapy: current status and perspectives. Cell Transplant. 23(9), 1045 (2013). • A good review that introduces the mesenchymal stem cells can act through paracrine mechanisms.
- 6. Exosomes derived from human embryonic mesenchymal stem cells promote osteochondral regeneration. Osteoarthr. Cartil. 24(12), 2135–2140 (2016).
- 7. Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. Stem Cell Res. 4(3), 214–222 (2010).
- 8. Mesenchymal stem cells secrete immunologically active exosomes. Stem Cells Dev. 23(11), 1233–1244 (2013).
- 9. Freeze-dried and GMP-compliant pharmaceuticals containing exosomes for acellular mesenchymal stromal cell immunomodulant therapy. Nanomedicine. 14(6), 753–765 (2019).
- 10. Mesenchymal stem cell-derived exosomes promote hepatic regeneration in drug-induced liver injury models. Stem Cell Res. Ther. 5(3), 76 (2014).
- 11. Integration of stem cell-derived exosomes with in situ hydrogel glue as a promising tissue patch for articular cartilage regeneration. Nanoscale 9(13), 4430–4438 (2017). • A good example of utilizing hydrogel to encapsulate exosomes in cartilage regeneration.
- 12. Exosomes derived from miR-140-5p-overexpressing human synovial mesenchymal stem cells enhance cartilage tissue regeneration and prevent osteoarthritis of the knee in a rat model. Theranostics 7(1), 180–195 (2017). • A good example of using genetic manipulation on mesenchymal stem cells to enhance the effect of exosomes.
- 13. Hepatocyte exosomes mediate liver repair and regeneration via sphingosine-1-phosphate. J. Hepatol. 64(1), 60–68 (2015).
- 14. Exosomes from human umbilical cord blood accelerate cutaneous wound healing through miR-21-3p-mediated promotion of angiogenesis and fibroblast function. Theranostics 8(1), 169–184 (2018).
- 15. . Mesenchymal stem cells derived exosomes and microparticles protect cartilage and bone from degradation in osteoarthritis. Sci. Rep. 7(1), 16214 (2017).
- 16. Exosomes derived from miR-92a-3p-overexpressing human mesenchymal stem cells enhance chondrogenesis and suppress cartilage degradation via targeting WNT5A. Stem Cell Res. Ther. 9(1), 247 (2018).
- 17. Exosomes from embryonic mesenchymal stem cells alleviate osteoarthritis through balancing synthesis and degradation of cartilage extracellular matrix. Stem Cell Res. Ther. 8(1), 189 (2017).
- 18. . MSC exosomes mediate cartilage repair by enhancing proliferation, attenuating apoptosis and modulating immune reactivity. Biomaterials 156, 16–27 (2018).
- 19. microRNA-21-5p dysregulation in exosomes derived from heart failure patients impairs regenerative potential. J. Clin. Invest. 129(6), 2237–2250 (2019). • A case that confirms the possible negative effect of exosomes in the tissue regeneration due to some specific components from the parent cells.
- 20. Comprehensive proteomic analysis of mesenchymal stem cell exosomes reveals modulation of angiogenesis via nuclear factor-kappab signaling. Stem Cells 34(3), 601–613 (2016).
- 21. . Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annu. Rev. Cell Dev. Biol. 30(1), 255–289 (2014). • A review that introduces the functions of exosomes rely on the process of their origin.
- 22. Platelet-derived growth factor regulates the secretion of extracellular vesicles by adipose mesenchymal stem cells and enhances their angiogenic potential. Cell Commun. Signal. 12(1), 26 (2014).
- 23. A stem cell-based approach to cartilage repair. Science 336(6082), 717–721 (2012). • A research that kartogenin was first found from 22,000 structurally diverse, druglike molecules using an image-based high-throughput screen system.
- 24. Kartogenin enhanced chondrogenesis in co-cultures of chondrocytes and bone mesenchymal stem cells. Tissue Eng. Part A 24(11–12), 990–1000 (2018).
- 25. . Kartogenin, transforming growth factor-β1 and bone morphogenetic protein-7 coordinately enhance lubricin accumulation in bone-derived mesenchymal stem cells. Cell Biol. Int. 39(9), 1026–1035 (2015).
- 26. Exosomes from human synovial-derived mesenchymal stem cells prevent glucocorticoid-induced osteonecrosis of the femoral head in the rat. Int. J. Biol. Sci. 12(10), 1262–1272 (2016).
- 27. . Regeneration of articular cartilage using adipose stem cells. J. Biomed. Mater. Res. A 104(7), 1830–1844 (2016).
- 28. . Stem cell-derived extracellular vesicles as a novel potential therapeutic tool for tissue repair. Stem Cells Transl. Med. 6(9), 1753–1758 (2017).
- 29. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 9(6), 654–659 (2007).
- 30. Exosomes as intercellular signaling organelles involved in health and disease: basic science and clinical applications. Int. J. Mol. Sci. 14(3), 5338–5366 (2013).
- 31. Expression and role of c-myc in chondrocytes undergoing endochondral ossification. J. Biol. Chem. 268(13), 9645–9652 (1993).
- 32. Effects of microRNA-24 targeting C-myc on apoptosis, proliferation, and cytokine expressions in chondrocytes of rats with osteoarthritis via MAPK signaling pathway. J. Cell. Biochem. 119(10), 7944–7958 (2018).
- 33. RUNX1 is essential for mesenchymal stem cell proliferation. Proc. Natl Acad. Sci. USA 111(46), 16389–16394 (2014).
- 34. Runx1/AML1/Cbfa2 mediates onset of mesenchymal cell differentiation toward chondrogenesis. J. Bone Miner. Res. 20(9), 1624–1636 (2005).
- 35. Runx1 and Runx2 cooperate during sternal morphogenesis. Development 137(7), 1159 (2010).
- 36. Knockout of ADAMTS5 does not eliminate cartilage aggrecanase activity but abrogates joint fibrosis and promotes cartilage aggrecan deposition in murine osteoarthritis models. J. Orthop. Res. 29(4), 516–522 (2011).
- 37. Exosomes from IL-1β stimulated synovial fibroblasts induce osteoarthritic changes in articular chondrocytes. Arthritis Res. Ther. 16(4), R163 (2014).
- 38. . ExoCarta 2012: database of exosomal proteins, RNA and lipids. Nucleic Acids Res. 40(Database issue), D1241–D1244 (2012).